10-years mortality risk estimation for gastric cancer patients based on clinicopathological factors

In order to create a nomogram for the gastric cancer no comprehensive study has been performed in Turkey so far and in our study, we tried to forecast the 10-year survival by using risk factors in patients without distant metastasis, who have not previously been diagnosed with another cancer but who underwent curative surgery.

The data of 411 patients who underwent gastrectomy for gastric cancer between January 2010 and January 2020 in Surgical Oncology Department were retrospectively examined.

It has been shown statistically that the high RDW value point to poor survival (p <0.001). There were 173 patients with ≤3.5g/dl and 238 patients with> 3.5g/dl. It was found out statistically significant that hypoalbuminemia indicated poor survival (p <0.001). Moreover, it was determined that high CEA and Ca19-9 with lymphovascular invasion were to be statistically significant with prognosis (p <0.001). On the based of all this data, we have created a dekstop application for the mortality estimation.

We think that this model will ensure individualization of the treatment for patients and will contribute to the patient's compliance with the treatment by strengthening the communication between the physician.

Gastric cancer, Gastrectomy, Survival analysis, Prognosis.